๐—Ÿ๐—ผ๐—ป๐—ด ๐—ง๐—ฒ๐—ฟ๐—บ ยฎโ„ข
19.7K subscribers
287 photos
3 files
17 links
In this Long term call monthly 1-3 call given holding period 1-3yrs
More premium Multibagger jackpot call msg me @Shortterm_bot

I am not SEBI registered analyst All the stocks are educational purpose,consulting your financial advisor before buying
Download Telegram
Revenue breakup
โšก2๐Ÿ‘1๐Ÿ”ฅ1๐Ÿ‘1
Citywise pre sales contribution
โค2๐Ÿ‘2๐Ÿ”ฅ2๐Ÿ‘1๐Ÿ‘Œ1
#SALES #GROWTH

In FY24, revenue grew by 35% YoY to ~โ‚น3,036 cr, led by project deliveries totaling ~12.5 million sq ft. The pre-sales improved by 84% YoY to ~โ‚น22,527 cr. Whereas, the sales volume stood at 20 million sq ft i.e., an increase of 31% YoY. marking a 84% year-onyear growth. The average realization during FY24 was โ‚น12,674 per sq ft for group housing and โ‚น4,280 sq ft for plotted lands. The company launched its first ever hospitality development project Taj The Trees in Vikhroli, Mumbai with 151 keys. The company added 10 new projects of business development with estimated booking value of ~โ‚น21,225 cr. In 9M FY25, the company did a booking of ~โ‚น19,281 cr up 48% YoY with a total area sales of 18.21 million sq. ft. It delivered 11.9 million sq ft. Average realization was ~โ‚น10,588 psf. The revenue registered was โ‚น2,801 cr.
๐Ÿ”ฅ2๐Ÿ‘1๐Ÿซก1
#EBITDA #GROWTH

Cost of material consumed contributes the highest of the total expense which majorly includes Land and development rights, construction, material and labor, architect fees and other costs.Whereas in case of other expenses, project maintenance cost, advertisement and marketing expense and consultancy charges are major contributors. In FY24, the EBITDA loss was of โ‚น129.7 cr. In Q1 FY24, EBITDA adjusted for provision done of โ‚น155 cr for (repair, maintenance and customer claims against one its project Godrej Summit in Gurugram which was found to have high chloride content in concrete, resulting in corrosion of steel. The company has made an offer to buyback the sold units and has bought back 100 apartments so far and spent โ‚น20- โ‚น25 cr till date. In 9M FY25, the EBITDA loss registered was โ‚น65.6 cr.
โค1๐Ÿ‘1๐Ÿ‘Œ1๐Ÿซก1
#PAT #GROWTH

FY23 PAT stood at โ‚น661.3 cr. Effective tax rate being 21%. In FY24, PAT stood at ~โ‚น719 cr and the profit from JV was ~โ‚น27.7 cr due to which the net consolidated PAT stood at ~โ‚น725 cr (this also included minority interest adjustment of โ‚น21.8 cr). In 9M FY25, the PAT registered was at โ‚น1,094 cr excluding share associate loss of โ‚น83.2 cr. The other income for Q1 FY25 was ~โ‚น960 cr which was due to sale of 5% equity stake held by it in Godrej Green Homes Private Limited ('GGHPL") (one of its joint venture entities), resulting Into gain of โ‚น46.66 cr which has been included in other income. The group's remaining investments have been fair valued as per IND AS 109 and resultant gain has been recorded under the head other Income.
๐Ÿ‘1๐Ÿ”ฅ1๐Ÿ‘1๐Ÿซก1
#EBITDA #MARGIN

On account of following project completion method, expenses are accounted in the current year itself irrespective of the project getting completed or not. Completion of companyโ€™s owned projects other than the oneโ€™s in joint venture and joint development will help in improving the margins. The booking value achieved in FY24 is expected to yield over โ‚น6,000 cr EBIT and โ‚น3,300 cr net profit in due course. Additionally, their pursuit of sustained growth was evident through the addition of 10 new projects, with an estimated revenue potential of approximately ~โ‚น21,225 Cr. In 9M FY25, the EBITDA margin was at negative 2%.
โšก1๐Ÿ”ฅ1๐Ÿ‘1๐Ÿ‘Œ1
#ROE

The company raised โ‚น3,750 cr through Qualified Institutional Placement (QIP) in March 2021 and another round of QIP in June 2019 of โ‚น2,100 cr. The equity raised was specifically timed to take advantage of a countercyclical investment strategy and the proceeds are being used to fund growth opportunities ahead. In FY24, the net worth was at โ‚น9,993 cr and net profit was at โ‚น747 cr (this includes profit of share associate of ~โ‚น28 cr). The ROE for the year improved to 7.7%.
๐Ÿ‘2๐Ÿ”ฅ2โšก1
#COMPANY #POTENTIAL

โ€ข The market size of Indiaโ€™s real estate sector is expected to reach USD 1 trillion by FY 2030 and the market is projected to increase at a CAGR of 19.5%. The market is anticipated to reach USD 650 Billion by FY 2025 and contribute 11-13% of the countryโ€™s GDP. โ€ข Housing sales in CY24 stood at ~4.60 lakh units, a 2% decline from CY23's figure of 4.77 lakh units. However, the total value of housing sales rose by 16%, from โ‚น4.88 lakh cr in 2023 to โ‚น5.68 lakh crore in 2024. This reflects increased prices despite a minor sales volume dropโ€‹โ€‹. Top cities contributing to these sales were MMR, Pune, Bengaluru, Hyderabad, and NCR, accounting for 92% of total salesโ€‹. โ€ข New launches in CY24 saw a decline of 7%, with 4.13 lakh units compared to 4.46 lakh units in CY23. This reduction is attributed to slower approval processes during election periodsโ€‹. There was a strong focus on premium and luxury housing, with a significant rise in homes priced above โ‚น2.5 cr, which saw a 66% increase in new launches in 2024. limited new supply, improving market efficiency. โ€ข Inventory across the top 7 cities decreased by 8% in 2024, with 5.53 lakh units available in the primary sales market. Pune recorded the highest decline, with a 20% reduction in unsold stockโ€‹. This reduction in inventory was driven by high demand and โ€ข Mumbai, being the largest real estate market in the country is set for a major boom, which will further add to the overall surge. For close to 5 years, Mumbai has resembled a gigantic construction site. A new coastal road, a metro rail and a trans harbor link are among the many ongoing infrastructure projects that are meant to transform Indiaโ€™s commercial capital into a modern and efficient city. As these projects complete over the next few years, new micro markets will open in and around Mumbai, as commuting would become easier. That will boost real estate development further.
๐Ÿ‘2โšก1๐Ÿ”ฅ1๐Ÿ‘1๐Ÿซก1
#COMPANY #OUTLOOK

โ€ข In FY25, the company had envisaged to grow residential bookings to over โ‚น27,000 cr through the launch of many new projects combined with strong sustenance sales and it achieved โ‚น29,444 cr of bookings for the year wth 25.7 million sq ft of sales. โ€ข The Ashok Vihar project Phase 1, Worli, Carmichael, Vikhroli project are expected to be launched in FY26. โ€ข The company targets ROE of 20% going forward. โ€ข They focus to deliver atleast 15% net profit margin, going forward. โ€ข It is comfortable with net gearing ratio between ~0.5:1 to 1:1 which gives them the room for further addition of debt. The company will have a cap on net debt of โ‚น10,000 crore. โ€ข The EBITDA margin is expected to be in the range of 25%-30% for residential projects but for plotted developments it would be higher. This can also be higher with change in mix of projects in different cities. โ€ข The company acquired ~53 acres of land in Joka, Kolkata. It offers ~1.3 million sq ft of saleable area comprising primarily residential plotted development with an estimated revenue potential of ~โ‚น500 cr. โ€ข In 9M FY25, they have added 12 new projects with a total estimated saleable area of ~16.9 million sq ft and total estimated booking value potential of ~โ‚น23,450 crore and have thereby surpassed the full year guidance of โ‚น20,000 crore.
๐Ÿ‘5๐Ÿ”ฅ2๐Ÿ‘Œ2
Godrej Properties 1800-2100
Expected level 2600
Support 1680
โšก5๐Ÿ‘2๐Ÿ”ฅ2
Good morning
๐Ÿ‘2๐Ÿ†’2๐Ÿ™1๐Ÿ•Š1
Laxmi Organic Industries Limited company details report

Laxmi Organic Industries Limited, incorporated in 1989 is a leading manufacturer of Acetyl Intermediates and Specialty Intermediates with almost three decades of experience in large scale manufacturing of chemicals. It started manufacturing glacial acetic acid in 1992, and thereafter moved on to manufacturing of ethyl acetate in 1996. In Fiscal 2010, it commenced manufacturing of Specialty Intermediates by acquiring Clariantโ€™s diketene business. The companyโ€™s product portfolio is currently divided into three broad categories, namely the Acetyl Intermediates, Speciality Intermediates and Fluorospeciality Intermediates. a) The Acetyl Intermediates include ethyl acetate, acetaldehyde, fuel-grade ethanol and other proprietary solvents. The company is currently amongst the largest manufacturers of ethyl acetate in India with a market share of ~30% and is the only Indian company with on ground presence in Europe for over ten years now. The acetyl products have applications in diverse industries such as pharmaceutical formulations, agrochemicals, ink & paints, coatings, packaging, adhesives and fragrance & flavour. b) The Specialty Intermediates comprises of ketene & diketene derivatives including esters, acetic anhydride, amides, and arylides. The company is the manufacturer of diketene derivatives in India with a market share of ~50%. The specialty intermediates have applications in pharmaceuticals, agrochemicals, dyes & pigments, flavour & fragrance, paints & coatings, flame redundant, and electronics.
๐Ÿ‘6โค1๐Ÿ‘Œ1
c) The Fluoro speciality Intermediates business vertical of Laxmi Organic Industries is a highly specialized segment with complex chemistry and limited competition. Leveraging the acquisition of Miteni SpAโ€™s Fluoro Specialities and electrochemical fluorination assets, the company has gained access to world-class technology, infrastructure, and a diverse product portfolio with over 100 offerings. With a dedicated facility in Lote-Parshuram, Maharashtra, the company is strategically positioned to establish a strong foothold in the Fluoro speciality Intermediates market. Fluoro speciality intermediates manufactured by the company will find applications in agrochemicals, cosmetics, flavours & fragrances, dyes & pigments, and in the medium to long term in electronics and automotive. The company has 50+ products and 620+ active customers. It has 4 manufacturing facilities (including two upcoming manufacturing facilities at Lote & Dahej). It expanded its scale of operations and global footprint with customers in over 52 countries including China, Netherlands, Russia, Singapore, United Arab Emirates, United Kingdom and United States of America.
โค1๐Ÿ”ฅ1๐Ÿซก1
#SALES #GROWTH

In FY24, the consolidated sales grew by 2.6% YoY to โ‚น2,865 cr. The growth was led by 20% YoY volume growth while price realization remained under pressure. Segment wise, the essentials segment sales grew by ~3% YoY and specialties segment sales grew by ~15% YoY. Industry wise, the agrochemical segment continues to face intense competition, and pricing in the pharma segment remains under pressure. Geography wise, the growth was led by domestic market and North America market while Europe market witnessed weak demand for products. In 9M FY25, the sales grew by 9.6% YoY to โ‚น2,276 cr led by 15% volume growth across both business segment. Segment wise, the essentials segment sales grew by 5% YoY and specialties segment sales grew by 20% YoY. The company witnessed volume growth mainly in Q2 FY25 of 14% YoY and in Q3 FY25 of 17% YoY. The revenue from domestic stood at 64% and exports at 36% in 9M FY25.
๐Ÿ‘2๐Ÿ”ฅ1๐Ÿซก1
#EBITDA #GROWTH

In FY24, the EBITDA grew by 7% YoY to โ‚น256 cr because of decline in power & fuel cost and other expenses. The power & fuel cost declined by 9% YoY to โ‚น229 cr (v/s โ‚น252 cr in FY23) led by reduced coal prices. Segment wise, the specialties segment contributed 67% (FY23: 69%) to the EBITDA and essentials segment contributes about 33% (FY23: 31%) to the EBITDA. The companyโ€™s loss of profit insurance claim for FY22 was settled in Q4 FY24 which added โ‚น10 cr to the EBITDA. During the year, the company witnessed supply chain challenges due to the ongoing Red Sea crisis. The companyโ€™s key raw material are acetic acid and ethyl alcohol. The price of acetic acid is linked to crude oil prices. Similarly, the price of local ethyl alcohol, derived from sugarcane molasses, is cyclical. In 9M FY25, the EBITDA grew by 31% YoY to โ‚น221 cr led by strong growth in both the essentials and specialties segment.
โšก1๐Ÿ‘1
#PAT #GROWTH

In FY24, the PAT declined by 3.3% YoY to โ‚น121 cr. The decline in profit was on account of increase in depreciation cost and higher effective tax rate. The depreciation cost increased by 47% YoY to โ‚น107 cr from โ‚น72 cr in FY23 mainly due to capitalization of two projects in subsidiary at site-2 in Mahad that came on stream in Q3 FY24 and Q4 FY24. The effective tax rate in FY24 stood at 29.4% in FY24 (v/s 27.9% in FY23). In 9M FY25, the PAT increased by 20% YoY to โ‚น92 cr. The depreciation cost increased by 11% YoY to โ‚น85 cr in 9M FY25 due to capitalization of assets in Lote.
โšก1๐Ÿ”ฅ1๐Ÿ‘Œ1
#EBITDA #MARGIN

In FY24, the EBITDA margin expanded by 36 bps YoY to 8.9% because of decline in power & fuel cost and other expenses. During the year, the gross margin of the company contracted by 71 bps YoY to 32.8% because of increase in raw material cost. The companyโ€™s product ethyl acetate is a commodity product, and thus, vulnerable to volatility in raw material prices, which are governed by global supplydemand dynamics. The companyโ€™s focus on high margin specialties products in the di-ketene derivatives and fluorochemicals segment will provide a stability to its earnings and improves its margins. In 9M FY25, the EBITDA margin expanded by 158 bps YoY to 9.7% mainly led by improvement in gross margin on account of operational efficiency. Segment wise, the essentials segment margin expanded by 88 bps YoY to 4.6% and specialties segment margin expanded by 169 bps YoY to 20.8%.
โšก1๐Ÿ‘1๐Ÿ‘1๐Ÿฆ„1
#PAT #MARGIN

In FY24, the PAT margin contracted by 26 bps YoY to 4.2%. Other income during the year increased to โ‚น28 cr from โ‚น17.5 cr in FY23. In 9M FY25, the PAT margin expanded by 35 bps YoY to 4%.
๐Ÿ‘2๐Ÿ”ฅ2โšก1๐Ÿ‘1